Study Stopped
Changed plans
Identity Development in Youth With Neuromuscular Diseases
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
Up to 20% of the adolescents worldwide are diagnosed with a chronic illness. Although it's known that these young people suffer from a wide range of physical discomfort, in real life they have to cope with much more challenges whether or not caused by their physical situation. Psychiatric disorders (e.g. ASS, ADHD or depression) are more often diagnosed in this population compared to their healthy peers. The causal mechanisms for this higher risk, however, are yet unknown. This project examines three underlying intrapersonal processes possibly having an impact on the evolution of these secondary symptoms. Previous research confirmed the significant impact of having a chronic illness on the development of identity and the association with a higher prevalence of depressive symptoms. Identity formation is a crucial developmental task to transfer from a child to an independent, responsible adult. We believe this developmental task is more at risk for youngsters and young adults suffering from a physical disability, caused by a neuromuscular disease. In this longitudinal research project, we investigate the development of identity in youth with a neuromuscular disease, compared to healthy peers and compared to a group of peers with a non-visible chronical illness. We also evaluate the impact of the degree of physical functioning on those mechanisms. Second, we examine if parental behavior and parental functioning is linked with the formation of identity in a neuromuscular populations. Finally, the impact of identity formation on psychosocial outcomes (e.g. feelings of depression and anxiety, quality of life, …) is measured. By addressing these research questions, this project will add substantially to our knowledge on identity in chronic illness and can inform future prevention and intervention efforts targeting illness adaptation and parental functioning in order to prevent negative psychosocial outcomes and to optimize quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2019
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2018
CompletedFirst Posted
Study publicly available on registry
December 13, 2018
CompletedStudy Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2020
CompletedDecember 13, 2018
November 1, 2018
1.1 years
November 13, 2018
December 12, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Manifestation of identity in 120 patients with neuromuscular diseases
Identity development will be measured with specific questionnaires
up to year 1
Psychosocial functioning in 120 patients with neuromuscular diseases
Psychosocial functioning will be measures with specific questionnaires
up to year 1
Study Arms (1)
Children with neuromuscular diseases
Questionnaires will be administered by children with neuromuscular disease between 12 and 25 years and their parents
Interventions
Different questionnaires about identity development and psychosocial functioning will be administered
Eligibility Criteria
Children with neuromuscular diseases between 12 and 25 years
You may qualify if:
- confirmed diagnoses of a neuromuscular disorder;
- aged 12-25 years at baseline;
- last neuromuscular consult at our NMRC is 5 or less years ago;
- able to read and write Dutch;
- valid contact details available in the clinical database or the hospital information system.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nathalie Goemans, MD, PhD
UZ Leuven
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2018
First Posted
December 13, 2018
Study Start
January 1, 2019
Primary Completion
February 1, 2020
Study Completion
February 1, 2020
Last Updated
December 13, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share